Grants and Contributions:
Title:
Cannabis Compound – Human Receptor Knowledgebase
Agreement Number:
929618
Agreement Value:
$50,000.00
Agreement Date:
Jun 3, 2019 - Mar 6, 2020
Description:
Development of a comprehensive molecular knowledgebase linking cannabis compounds to human receptors and their associated therapeutic indications.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Lasalle, Quebec, CA H7S 2E4
Reference Number:
172-2019-2020-Q2-929618
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
763159480
Recipient Type:
For-profit organization
Amendment Date
Jun 3, 2019
Recipient's Legal Name:
Opportune Therapeutics Inc
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: